Henriette Ytting Lambert

Henriette Ytting Lambert serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in Gastroenterology and Hepatology. Her clinical work is based at Copenhagen University Hospital (Region Hovedstaden) with locations in Hvidovre and Copenhagen N.

Her research focuses on autoimmune liver diseases, particularly autoimmune hepatitis and primary biliary cholangitis, with emphasis on clinical proteomics for diagnostics, quality of life impacts, and metabolic complications. Lambert leads investigations into non-invasive biomarker discovery while examining how liver diseases interact with diabetes and affect patient-reported outcomes. Her work frequently employs multicenter European collaborations through the ERN RARE-LIVER network.

Recent publication trends reveal dominance in

• Autoimmune hepatitis pathophysiology (40% of output)
• Quality-of-life assessment methodologies (25%)
• Metabolomic/proteomic biomarker discovery (20%)
• European registry-based clinical research (15%)

with strong emphasis on translational applications. Lambert consistently appears as senior/corresponding author on studies involving Danish patient cohorts and European collaborations.

Lambert actively contributes to clinical guideline development, with her work referenced in clinical guideline sources. Her research receives significant attention across academic platforms with 17 Mendeley readers and mentions on professional networks including X (formerly Twitter) and Bluesky.

Her collaborative network spans 15+ European institutions through the ERN RARE-LIVER consortium, focusing on standardized care protocols for rare liver diseases. Current projects include the R-LIVER registry analyzing unmet needs in autoimmune hepatitis management across 20 European centers.